Moberg Pharma issues a bond loan in the amount of SEK 300 million on the Nordic bond market to finance growth and acquisitions
STOCKHOLM, January 25th, 2016. Moberg Pharma AB (OMX: MOB) announces that the company has decided to issue a five-year senior unsecured bond loan in the amount of SEK 300 million with maturity on January 29th, 2021.The bond loan will give a floating rate coupon of Stibor 3m + 6.00% and have a total framework amount of SEK 600 million. Moberg Pharma intends to apply for listing of the bond loan on Nasdaq Stockholm within 30 days. To enable future growth, Moberg Pharma intends to make significant investments during 2016, focusing on strengthening brand platforms for the company’s strategic